Insulin resistance associated to obesity: the link TNF-alpha

References

• Aggarwal B B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745–756
   PubMed Web of Science ®Google Scholar
• Ahmad F, Azevedo J L, Cortright R, Dohm G L, Goldstein B J. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 1997; 100: 449–458
   PubMed Web of Science ®Google Scholar
• Altomonte J, Harbaran S, Richter A, Dong H. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 2003; 52: 958–963
   PubMed Web of Science ®Google Scholar
• Arner P. The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 2003; 14: 137–145
   PubMed Web of Science ®Google Scholar
• Bento J L, Palmer N D, Mychaleckyj J C, Lange L A, Langefeld C D, Rich S S, Freedman B I, Bowden D W. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 2004; 53: 3007–3012
   PubMed Web of Science ®Google Scholar
• Bouzakri K, Zierath J R. MAP4K4 gene silencing in human skeletal muscle prevents tumour necrosis factor-alpha-induced insulin resistance. J Biol Chem 2007; 282: 7783–7789
   PubMed Web of Science ®Google Scholar
• Bruce C R, Dyck D J. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumour necrosis factor-alpha. Am J Physiol Endocrinol Metab 2004; 287: E616–E621
   Google Scholar
• Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277–359
   PubMed Web of Science ®Google Scholar
• Carlson C J, Koterski S, Sciotti R J, Poccard G B, Rondinone C M. Enhanced basal activation of mitogen–activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 2003; 52: 634–641
   PubMed Web of Science ®Google Scholar
• Carswell E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumours. Proc Natl Acad Sci USA 1975; 72: 3666–3670
   PubMed Web of Science ®Google Scholar
• Cawthorn W P, Sethi J K. TNF-alpha and adipocyte biology. FEBS Lett 2008; 582: 117–131
   PubMed Web of Science ®Google Scholar
• Conejo R, de Alvaro C, Benito M, Cuadrado A, Lorenzo M. Insulin restores differentiation of Ras–transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway Oncogene. 2002; 21: 3739–3753, (JID – 8711562)
   Google Scholar
• Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007; 1773: 1358–1375
   PubMed Web of Science ®Google Scholar
• de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumour necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 2004; 279: 17070–17078
   PubMed Web of Science ®Google Scholar
• Delibegovic M, Bence K K, Mody N, Hong E G, Ko H J, Kim J K, Kahn B B, Neel B G. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B PTP1B. Mol Cell Biol 2007; 27: 7727–7734
   PubMed Web of Science ®Google Scholar
• Ding G, Cheng L, Qin Q, Frontin S, Yang Q. PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signalling in cultured cardiomyocytes. J Mol Cell Cardiol 2006; 40: 821–828
   PubMed Web of Science ®Google Scholar
• Dirks A J, Leeuwenburgh C. Tumour necrosis factor alpha signalling in skeletal muscle: effects of age and caloric restriction. J Nutr Biochem 2006; 17: 501–508
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy A L, Normandin D, Cheng A, Himms-Hagen J, Chan C C, Ramachandran C, Gresser M J, Tremblay M L, Kennedy B P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283: 1544–1548
   PubMed Web of Science ®Google Scholar
• Fernandez-Veledo S, Hernandez R, Teruel T, Mas J A, Ros M, Lorenzo M. Ceramide mediates TNF-alpha-induced insulin resistance on GLUT4 gene expression in brown adipocytes. Arch Physiol Biochem 2006a; 112: 13–22
   PubMedGoogle Scholar
• Fernandez-Veledo S, Nieto-Vazquez I, Rondinone C M, Lorenzo M. Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression. Diabetologia 2006b; 49: 3038–3048
   PubMed Web of Science ®Google Scholar
• Fontaine-Bisson B, Wolever T M, Chiasson J L, Rabasa-Lhoret R, Maheux P, Josse R G, Leiter L A, Rodger N W, Ryan E A, Connelly P W, Corey P N, El-Sohemy A. Genetic polymorphisms of tumour necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr 2007; 86: 768–774
   PubMed Web of Science ®Google Scholar
• Fujii N, Jessen N, Goodyear L J. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 2006; 291: E867–E877
   PubMedGoogle Scholar
• Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Abe M, Shojima N, Fukushima Y, Kikuchi M, Oka Y, Asano T. Three mitogen-activated protein kinases inhibit insulin signalling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 2003; 17: 487–497
   PubMed Web of Science ®Google Scholar
• Gao Z, Zuberi A, Quon M J, Dong Z, Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumour necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 2003; 278: 24944–24950
   PubMed Web of Science ®Google Scholar
• Gum R J, Gaede L L, Koterski S L, Heindel M, Clampit J E, Zinker B A, Trevillyan J M, Ulrich R G, Jirousek M R, Rondinone C M. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signalling in ob/ob mice. Diabetes 2003; 52: 21–28
   PubMed Web of Science ®Google Scholar
• Hernandez R, Teruel T, de Alvaro C, Lorenzo M. Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-alpha induction of p38 and p42/p44 mitogen-activated protein kinases. Diabetologia 2004; 47: 1615–1624
   PubMed Web of Science ®Google Scholar
• Hernandez R, Teruel T, Lorenzo M. Akt mediates insulin induction of glucose uptake and up-regulation of GLUT4 gene expression in brown adipocytes. FEBS Lett 2001; 494: 225–231
   PubMed Web of Science ®Google Scholar
• Hernandez R, Teruel T, Lorenzo M. Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes. Diabetologia 2003; 46: 1618–1628
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S. Mechanisms of TNF-alpha-induced insulin resistance [see comments]. Exp Clin Endocrinol Diabetes 1999; 107: 119–125
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003; 27(Suppl 3)S53–S55
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S, Arner P, Caro J F, Atkinson R L, Spiegelman B M. Increased adipose tissue expression of tumour necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415
   PubMed Web of Science ®Google Scholar
• Hotamisligil G S, Murray D L, Choy L N, Spiegelman B M. Tumour necrosis factor alpha inhibits signalling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854–4858
   PubMed Web of Science ®Google Scholar
• Jager S, Handschin C, St-Pierre J, Spiegelman B M. AMP-activated protein kinase AMPK action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA 2007; 104: 12017–12022
   PubMed Web of Science ®Google Scholar
• Jiao K, Liu H, Chen J, Tian D, Hou J, Kaye A. Roles of plasma interleukin-6 and tumour necrosis factor-alpha and FFA and TG in the development of insulin resistance induced by high-fat diet. Cytokine 2008; 42: 161–169
   PubMed Web of Science ®Google Scholar
• Kern P A, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumour necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745–E751
   PubMed Web of Science ®Google Scholar
• Khan A H, Pessin J E. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 2002; 45: 1475–1483, (JID – 0006777)
   PubMed Web of Science ®Google Scholar
• Klaman L D, Boss O, Peroni O D, Kim J K, Martino J L, Zabolotny J M, Moghal N, Lubkin M, Kim Y B, Sharpe A H, Stricker-Krongrad A, Shulman G I, Neel B G, Kahn B B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000; 20: 5479–5489
   PubMed Web of Science ®Google Scholar
• Kramer D K, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves P M, Krook A. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 2007; 282: 19313–19320
   PubMed Web of Science ®Google Scholar
• Kramer D K, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, Kannisto K, Wallberg-Henriksson H, Ehrenborg E, Zierath J R, Krook A. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 2005; 54: 1157–1163
   PubMed Web of Science ®Google Scholar
• Li G, Barrett E J, Barrett M O, Cao W, Liu Z. Tumour necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Endocrinology 2007; 148: 3356–3363
   PubMed Web of Science ®Google Scholar
• Lo J, Bernstein L E, Canavan B, Torriani M, Jackson M B, Ahima R S, Grinspoon S K. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab 2007; 293: E102–E109
   PubMed Web of Science ®Google Scholar
• Lofgren P, van H V, Reynisdottir S, Naslund E, Ryden M, Rossner S, Arner P. Secretion of tumour necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 2000; 49: 688–692
   PubMed Web of Science ®Google Scholar
• Lorenzo M, Teruel T, Hernandez R, Kayali A G, Webster N J. PLCgamma participates in insulin stimulation of glucose uptake through activation of PKCzeta in brown adipocytes. Exp Cell Res 2002; 278: 146–157, (JID – 0373226)
   PubMed Web of Science ®Google Scholar
• Lumeng C N, Bodzin J L, Saltiel A R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175–184
   PubMed Web of Science ®Google Scholar
• Memon R A, Feingold K R, Moser A H, Fuller J, Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 1998; 274: E210–E217
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007; 293: E444–E452
   PubMed Web of Science ®Google Scholar
• Nieto-Vazquez I, Fernandez-Veledo S, de Alvaro C, Rondinone C M, Valverde A M, Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumour necrosis factor-{alpha}-induced insulin resistance diabetes. 2007; 56: 404–413
   Google Scholar
• Old L J. Tumour necrosis factor TNF. Science 1985; 230: 630–632
   PubMed Web of Science ®Google Scholar
• Olefsky J M. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 2000; 106: 467–472, (JID – 7802877)
   PubMed Web of Science ®Google Scholar
• Pirola L, Johnston A M, Van Obberghen E. Modulation of insulin action. Diabetologia 2004; 47: 170–184
   PubMed Web of Science ®Google Scholar
• Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath J R, Pedersen B K. Tumour necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005; 54: 2939–2945
   PubMed Web of Science ®Google Scholar
• Ramsay T G. Fat cells. Endocrinol Metab Clin North Am 1996; 25: 847–870
   PubMed Web of Science ®Google Scholar
• Ren T, He J, Jiang H, Zu L, Pu S, Guo X, Xu G. Metformin reduces lipolysis in primary rat adipocytes stimulated by tumour necrosis factor-alpha or isoproterenol. J Mol Endocrinol 2006; 37: 175–183
   PubMed Web of Science ®Google Scholar
• Rosenvinge A, Krogh-Madsen R, Baslund B, Pedersen B K. Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNF-alpha therapy. Scand J Rheumatol 2007; 36: 91–96
   PubMed Web of Science ®Google Scholar
• Ruan H, Miles P D, Ladd C M, Ross K, Golub T R, Olefsky J M, Lodish H F. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumour necrosis factor-alpha: implications for insulin resistance. Diabetes 2002; 51: 3176–3188
   PubMed Web of Science ®Google Scholar
• Ruan H, Pownall H J, Lodish H F. Troglitazone antagonizes tumour necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 2003; 278: 28181–28192
   PubMed Web of Science ®Google Scholar
• Sbarsi I, Falcone C, Boiocchi C, Campo I, Zorzetto M, De S A, Cuccia M. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol 2007; 20: 145–154
   PubMed Web of Science ®Google Scholar
• Schrauwen-Hinderling V B, Kooi M E, Hesselink M K, Moonen-Kornips E, Schaart G, Mustard K J, Hardie D G, Saris W H, Nicolay K, Schrauwen P. Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 2005; 13: 2088–2094
   PubMedGoogle Scholar
• Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, Sbraccia P, Hribal M L, Lauro R, Federici M. Mice heterozygous for tumour necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 2007; 56: 2541–2546
   PubMed Web of Science ®Google Scholar
• Sharma A M, Chetty V T. Obesity, hypertension and insulin resistance. Acta Diabetol 2005; 42(Suppl 1)S3–S8
   PubMed Web of Science ®Google Scholar
• Shrestha S, Bhattarai B R, Lee K H, Cho H. Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs. Bioorg Med Chem 2007; 15: 6535–6548
   PubMed Web of Science ®Google Scholar
• Souza S C, Yamamoto M T, Franciosa M D, Lien P, Greenberg A S. BRL 49653 blocks the lipolytic actions of tumour necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 1998; 47: 691–695
   PubMed Web of Science ®Google Scholar
• Steffensen K R, Gustafsson J A. Putative metabolic effects of the liver X receptor LXR. Diabetes 2004; 53(Suppl 1)S36–S42
   PubMed Web of Science ®Google Scholar
• Steinberg G R, Michell B J, van Denderen B J, Watt M J, Carey A L, Fam B C, Andrikopoulos S, Proietto J, Gorgun C Z, Carling D, Hotamisligil G S, Febbraio M A, Kay T W, Kemp B E. Tumour necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signalling. Cell Metab 2006; 4: 465–474
   PubMed Web of Science ®Google Scholar
• Teruel T, Hernandez R, Lorenzo M. Ceramide mediates insulin resistance by tumour necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001; 50: 2563–2571, (JID – 0372763)
   PubMed Web of Science ®Google Scholar
• Teruel T, Hernandez R, Rial E, Martin-Hidalgo A, Lorenzo M. Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats. Diabetologia 2005; 48: 1180–1188
   PubMed Web of Science ®Google Scholar
• Tracey K J, Wei H, Manogue K R, Fong Y, Hesse D G, Nguyen H T, Kuo G C, Beutler B, Cotran R S, Cerami A. Cachectin/tumour necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988; 167: 1211–1227
   PubMed Web of Science ®Google Scholar
• Uysal K T, Wiesbrock S M, Marino M W, Hotamisligil G S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610–614
   PubMed Web of Science ®Google Scholar
• Valverde A M, Benito M, Lorenzo M. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol Scand 2005; 183: 59–73
   PubMedGoogle Scholar
• Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C zeta/lambda activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 2002; 51: 1052–1059
   PubMed Web of Science ®Google Scholar
• Weisberg S P, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel R L, Ferrante A W, Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115–124
   PubMed Web of Science ®Google Scholar
• White M F. Insulin signalling in health and disease. Science 2003; 302: 1710–1711
   PubMed Web of Science ®Google Scholar
• Wu Y, Ouyang J P, Wu K, Wang S S, Wen C Y, Xia Z Y. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br J Pharmacol 2005; 146: 234–243
   PubMed Web of Science ®Google Scholar
• Xue B, Kim Y B, Lee A, Toschi E, Bonner-Weir S, Kahn C R, Neel B G, Kahn B B. Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 2007; 282: 23829–23840
   PubMed Web of Science ®Google Scholar
• Yuan M, Konstantopoulos N, Lee J, Hansen L, Li Z W, Karin M, Shoelson S E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293: 1673–1677, (JID – 0404511)
   PubMed Web of Science ®Google Scholar
• Zabolotny J M, Haj F G, Kim Y B, Kim H J, Shulman G I, Kim J K, Neel B G, Kahn B B. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 2004; 279: 24844–24851
   PubMed Web of Science ®Google Scholar
• Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord 2000; 24: 1392–1395
   PubMed Web of Science ®Google Scholar
• Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller D E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 1996; 271: 31771–31774
   PubMed Web of Science ®Google Scholar